The End of an Era?
Newsweek US|September 16, 2022
Companies are pushing for a post-pandemic return to the office. But it may not be possible to put the remote-work genie back in the bottle
JALEN SMALL
The End of an Era?

DURING THE MORE THAN TWO YEARS that the COVID-19 pandemic blanketed the U.S. economic landscape, millions of workers were able to work in remote or hybrid arrangements. But now, as the COVID pall has lifted, some Fortune 100 companies including Apple, Disney, and Tesla-are expecting their employees to work more days in the office, starting as soon as this month.

The anticipated shift toward more in-person work is creating controversy in corporate boardrooms, with company executives debating the value and effect of the remote and hybrid models that have become the norm over the past two-and-a-half years.

In the coming weeks and months, employers and their employees will have to make decisions that will have significant implications on the future of work, says Roger Martin, business analyst and former dean of the Rotman School of Management at the University of Toronto. "You had this great, natural experiment, where everybody had to work from home," Martin tells Newsweek. "Now a bunch of people who would have never chosen to work remotely not only got used to it, but even started to like it."

Martin sees this development as the greatest shift in the American workforce since the U.S. entered the Second World War. "My strongly held view is that things are never going back to exactly how they were," Martin says. "Firms are making a horrible mistake to force people back to work they're just begging for trouble."

The Remote Explosion

ACCORDING TO MCKINSEY & COMPANY'S American Opportunity Survey, some 92 million Americans, the equivalent of 58 percent of the workforce, have had the opportunity to work from home at least once a week in 2022, while some 35 percent have had the option to work from home five days a week.

この記事は Newsweek US の September 16, 2022 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Newsweek US の September 16, 2022 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

NEWSWEEK USのその他の記事すべて表示
AMERICA'S BEST LOYALTY PROGRAMS 2025
Newsweek US

AMERICA'S BEST LOYALTY PROGRAMS 2025

LOYALTY PROGRAMS HAVE BECOME A CORNERSTONE of the modern shopping experience, offering perks and rewards designed to keep customers returning for more.

time-read
3 分  |
February 21, 2025
Winning the Global Game
Newsweek US

Winning the Global Game

The U.S. holds more cards than China. Whether we keep our strategic advantage depends on how we play our hand

time-read
3 分  |
February 21, 2025
Solar Power
Newsweek US

Solar Power

Scientists' creation of a record-breaking \"artificial sun\" brings nuclear fusion energy a step closer to being a commercial reality

time-read
2 分  |
February 21, 2025
Trump vs. Deep State
Newsweek US

Trump vs. Deep State

The president and his efficiency chief Elon Musk have brought in a wave of policies affecting federal employees' jobs. Government workers spoke to Newsweek about the impact

time-read
6 分  |
February 21, 2025
MAD ABOUT THE GIRL
Newsweek US

MAD ABOUT THE GIRL

AS RENÉE ZELLWEGER REPRISES THE ICONIC CHARACTER, BRIDGET JONES' CREATOR - AND MILLIONS OF FANS, COULDN'T BE HAPPIER

time-read
10+ 分  |
February 21, 2025
Armed and Dangerous
Newsweek US

Armed and Dangerous

A Ukrainian colonel reveals how North Korean soldiers compared with their Russian allies

time-read
4 分  |
February 21, 2025
Patrick Gibson
Newsweek US

Patrick Gibson

WHEN YOU TAKE ON A ROLE THAT SOMEBODY ELSE MADE FAMOUS, IT'S not easy.

time-read
2 分  |
February 21, 2025
The AI Will See You Now
Newsweek US

The AI Will See You Now

A light-hearted study into artificial intelligence's ability to perform cognitive tasks has raised questions around the roles of AI and doctors in health care

time-read
6 分  |
February 21, 2025
Jasmin Savoy Brown
Newsweek US

Jasmin Savoy Brown

SHOWTIME'S YELLOWJACKETS IS REALLY TWO shows in one.

time-read
2 分  |
February 21, 2025
BIOTECH: Blood, Sweat and Tears
Newsweek US

BIOTECH: Blood, Sweat and Tears

Nine years in the making, Truvian's quick tabletop blood test promises to deliver where Theranos famously couldn't

time-read
6 分  |
February 14, 2025